Answers are grounded in this paper and cite their sources.
Low-dose atropine 0.01% was not effective in reducing AL progression in two studies. Treatment efficacy with low-dose atropine of 0.05% showed good efficacy. Spectacles (HAL and DIMS) and contact lenses (MiSight and Biofinity) may confer a comparable treatment benefit compared to atropine, to slow myopia progression.
No takes yet. Share an insight, caveat, or question.
Lança et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: